ADAG Projected Dividend Yield
ADS/Adagene Inc ( NASDAQ : ADAG )Adagene is a a holding company. Through its subsidiaries, Co. is principally engaged in research, development and production of monoclonal antibody drugs for cancers. Co.'s platform is designed to generate antibody candidates with functional epitopes and species cross-reactivity as highlighted by its immunotherapy pipeline. By utilizing its Dynamic Precision Library platform, Co. has developed a pipeline of product candidates in various stages of development, ranging from research and discovery to preclinical and clinical development. Co.'s clinical-stage pipeline consists of ADG106, ADG126 and ADG116. Co. also has a preclinical pipeline in various stages of development. 20 YEAR PERFORMANCE RESULTS |
ADAG Dividend History Detail ADAG Dividend News ADAG Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |